DIVIDEND ANNOUNCEMENT: Ord/Kamada Ltd (NASDAQ:KMDA) on 03/05/2025 declared a dividend of $0.2000 per share

Ord/Kamada Ltd (NASDAQ:KMDA) on 03/05/2025 declared a dividend of $ 0.2000 per share payable on April 07, 2025 to shareholders of record as of March 17, 2025. Dividend amount recorded is an increase of $ 0.2 from last dividend Paid.

Ord/Kamada Ltd (NASDAQ:KMDA) has paid dividends since 1970, has a current dividend yield of 0.0000000000% and has increased its dividends for 0 successive years.

Ord/Kamada Ltd's market cap is $ 295,751,230 and has a PE ratio of 23.61. The stock price closed yesterday at $ 6.61 and has a 52 week low/high of $ 4.74 and $ 9.15.

Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. Co. uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.

For more information on Ord/Kamada Ltd click here.